APP and Alzheimer disease: Then, Toyonaga et al. stated that [11C]UCB-J PET allows to differentiate hippocampal SUVRWB in APP/PS1 mice and in WT mice at baseline and to detect a significant increase in hippocampal SUVRWB after AD treatment with saracatinib.